Our recent studies also showed that NeuroD1 promotes tumorigenesis by downregulating the p53/p21 axis, thereby promoting cell cycle progression, and by upregulating glucose-6-phosphate dehydrogenase (G6PD) expression, thereby enhancing glucose metabolic reprogramming in tumor cells [41, 42]. Here, G6PD is linked to neoplasm.